Genesys Pharma receives Canadian approval to commence phase I trial with antisense AIDS treatment

被引：0
|
作者：
不详
机构：
来源：
DRUG NEWS & PERSPECTIVES | 1997年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [31] Photodynamic Therapy for the Treatment of Vertebral Metastases: A Phase I Clinical Trial
    Fisher, Carl
    Ali, Zakariya
    Detsky, Jay
    Sahgal, Arjun
    David, Elizabeth
    Kunz, Monica
    Akens, Margarete
    Chow, Edward
    Whyne, Cari
    Burch, Shane
    Wilson, Brian C.
    Yee, Albert
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5766 - 5776
  • [32] Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
    Traynor, Anne M.
    Thomas, James P.
    Ramanathan, Ramesh K.
    Mody, Tarak D.
    Alberti, Dona
    Wilding, George
    Bailey, Howard H.
    [J]. INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 316 - 322
  • [33] Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma
    Thomas Martin
    Stephen Strickland
    Martha Glenn
    Eric Charpentier
    Hélène Guillemin
    Karl Hsu
    Joseph Mikhael
    [J]. Blood Cancer Journal, 9
  • [34] A phase I trial of CTLA4Ig treatment in MS
    Khoury, SJ
    Viglietta, V
    Buckle, G
    Hafler, D
    Bourcier, K
    Guttmann, C
    Bikowski, M
    Rusche, J
    Landy, H
    McNally, J
    Jauregui, K
    [J]. NEUROLOGY, 2005, 64 (06) : A393 - A393
  • [35] Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma
    Martin, Thomas
    Strickland, Stephen
    Glenn, Martha
    Charpentier, Eric
    Guillemin, Helene
    Hsu, Karl
    Mikhael, Joseph
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (4)
  • [36] INTERFERON-ALPHA PLUS AZIDOTHYMIDINE (AZT) IN AIDS-ASSOCIATED KAPOSIS-SARCOMA (KS/AIDS) - A PHASE-I TRIAL OF THE MEMORIAL-SLOAN-KETTERING AIDS TREATMENT AND EVALUATION UNIT
    KROWN, SE
    BUNDOW, D
    TONG, WP
    GOLD, JWM
    FLOMENBERG, N
    FANUCCHI, M
    ARMSTRONG, D
    [J]. JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 688 - 688
  • [37] Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
    Ma, Julian K-C.
    Drossard, Juergen
    Lewis, David
    Altmann, Friedrich
    Boyle, Julia
    Christou, Paul
    Cole, Tom
    Dale, Philip
    van Dolleweerd, Craig J.
    Isitt, Valerie
    Katinger, Dietmar
    Lobedan, Martin
    Mertens, Hubert
    Paul, Mathew J.
    Rademacher, Thomas
    Sack, Markus
    Hundleby, Penelope A. C.
    Stiegler, Gabriela
    Stoger, Eva
    Twyman, Richard M.
    Vcelar, Brigitta
    Fischer, Rainer
    [J]. PLANT BIOTECHNOLOGY JOURNAL, 2015, 13 (08) : 1106 - 1120
  • [38] A PHASE-I TRIAL OF RECOMBINANT IMMUNE (GAMMA)-INTERFERON IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    LANE, HC
    SHERWIN, SA
    MASUR, H
    GELMANN, EP
    ROOK, AH
    MANISCHEWITZ, JF
    QUINNAN, GV
    SMITH, P
    WAHL, S
    ALLYN, SP
    HIGGINS, SE
    MEGILL, ME
    FAUCI, AS
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A408 - A408
  • [39] A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer
    Adjei, AA
    Dy, GK
    Erlichman, C
    Reid, JM
    Sloan, JA
    Pitot, HC
    Alberts, SR
    Goldberg, RM
    Hanson, LJ
    Atherton, PJ
    Watanabe, T
    Geary, RS
    Holmlund, J
    Dorr, FA
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (01) : 115 - 123
  • [40] Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian Randomized MAC Treatment Trial
    Singer, J
    Thorne, A
    Phillips, P
    Rachlis, AR
    Miller, M
    Gill, MJ
    Smaill, FM
    Schlech, WF
    Senay, H
    Shafran, SD
    [J]. AIDS, 1999, 13 (05) : 575 - 582
12345